Literature DB >> 16520480

New treatments for malignant gliomas: careful evaluation and cautious optimism required.

Mark R Gilbert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16520480     DOI： 10.7326/0003-4819-144-5-200603070-00015

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

1.  Hydrogen bonded and stacked geometries of the temozolomide dimer.

Authors:  Okuma Emile Kasende; Jules Tshishimbi Muya; Vincent de Paul N Nziko; Steve Scheiner
Journal:  J Mol Model       Date:  2016-03-14       Impact factor: 1.810

2.  Synergistic suppression of noscapine and conventional chemotherapeutics on human glioblastoma cell growth.

Authors:  Qi Qi; Xia Liu; Shiyong Li; Harish C Joshi; Keqiang Ye
Journal:  Acta Pharmacol Sin       Date:  2013-05-27       Impact factor: 6.150

Review 3.  Molecular strategies for the treatment of malignant glioma--genes, viruses, and vaccines.

Authors:  Lee A Selznick; Mohammed F Shamji; Peter Fecci; Matthias Gromeier; Allan H Friedman; John Sampson
Journal:  Neurosurg Rev       Date:  2008-02-08       Impact factor: 3.042

4.  NHERF-1: modulator of glioblastoma cell migration and invasion.

Authors:  Kerri L Kislin; Wendy S McDonough; Jennifer M Eschbacher; Brock A Armstrong; Michael E Berens
Journal:  Neoplasia       Date:  2009-04       Impact factor: 5.715

5.  Repurposing Drugs in Oncology (ReDO)-chloroquine and hydroxychloroquine as anti-cancer agents.

Authors:  Ciska Verbaanderd; Hannelore Maes; Marco B Schaaf; Vikas P Sukhatme; Pan Pantziarka; Vidula Sukhatme; Patrizia Agostinis; Gauthier Bouche
Journal:  Ecancermedicalscience       Date:  2017-11-23

Review 6.  NHERF1 Between Promises and Hopes: Overview on Cancer and Prospective Openings.

Authors:  Matteo Centonze; Concetta Saponaro; Anita Mangia
Journal:  Transl Oncol       Date:  2018-02-20       Impact factor: 4.243
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.